HIV Coinfection
12
2
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
25%
3 trials in Phase 3/4
67%
6 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV
Pharmacist-Led Intervention to Improve TB Treatment Adherence
HIV And Parasitic Infection (HAPI) Study
Supporting Treatment Outcomes Among PWID
TB-CAPT EXULTANT - HIV
Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis
Optimizing Malaria Treatment for HIV-Malaria Co-infected Individuals
Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B